Interestingly, when applied to primary prostate tumors in the TCGA dataset, these genes clearly discriminated ERG-positive tumors with PTEN deficiency (by deletion or mutation) from wild-type tumors for both ERG fusion and PTEN loss (Fig. 8f). Here, PTEN is linked to prostate neoplasm.